While RSK2 and AKT are the two major substrates of PDPK1, we have shown that RSK2, not AKT, plays a central role as the downstream effector of PDPK1 in MM and MCL.22, 24. This evidence concerns the gene RPS6KA3 and Miyoshi myopathy.